ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Coryza Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2W6479
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Coryza Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Coryza Vaccine Market Research Report 2025

Code: QYRE-Auto-2W6479
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Inc
Merck
Boehringer Ingelheim
Ceva Santé Animale
Qilu Animal Health Products Co., Ltd.
Tianjin Ruipu Biotechnology Co., Ltd.
Harbin Pharmaceutical Group
Plyco Bioengineering Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Huahong Biological Engineering Co., Ltd.

Infectious Coryza Vaccine Market

The global market for Infectious Coryza Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Infectious Coryza Vaccine is used to prevent infectious rhinitis in chickens caused by Avian bacillus paragallinarum. The method is subcutaneous injection on the back of the neck.
North American market for Infectious Coryza Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Infectious Coryza Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Infectious Coryza Vaccine include Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Coryza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Coryza Vaccine.
The Infectious Coryza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Coryza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Coryza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Infectious Coryza Vaccine Market Report

Report Metric Details
Report Name Infectious Coryza Vaccine Market
Segment by Type
  • Monovalent Vaccine
  • Bivalent Vaccine
  • Trivalent Vaccine
Segment by Application
  • Retail
  • Online Sale
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Shandong Huahong Biological Engineering Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Infectious Coryza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Infectious Coryza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Infectious Coryza Vaccine Market report?

Ans: The main players in the Infectious Coryza Vaccine Market are Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Shandong Huahong Biological Engineering Co., Ltd.

What are the Application segmentation covered in the Infectious Coryza Vaccine Market report?

Ans: The Applications covered in the Infectious Coryza Vaccine Market report are Retail, Online Sale, Others

What are the Type segmentation covered in the Infectious Coryza Vaccine Market report?

Ans: The Types covered in the Infectious Coryza Vaccine Market report are Monovalent Vaccine, Bivalent Vaccine, Trivalent Vaccine

1 Infectious Coryza Vaccine Market Overview
1.1 Product Definition
1.2 Infectious Coryza Vaccine by Type
1.2.1 Global Infectious Coryza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monovalent Vaccine
1.2.3 Bivalent Vaccine
1.2.4 Trivalent Vaccine
1.3 Infectious Coryza Vaccine by Application
1.3.1 Global Infectious Coryza Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Retail
1.3.3 Online Sale
1.3.4 Others
1.4 Global Infectious Coryza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Infectious Coryza Vaccine Revenue 2020-2031
1.4.2 Global Infectious Coryza Vaccine Sales 2020-2031
1.4.3 Global Infectious Coryza Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Infectious Coryza Vaccine Market Competition by Manufacturers
2.1 Global Infectious Coryza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Infectious Coryza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Infectious Coryza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Infectious Coryza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Coryza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Coryza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Infectious Coryza Vaccine, Date of Enter into This Industry
2.8 Global Infectious Coryza Vaccine Market Competitive Situation and Trends
2.8.1 Global Infectious Coryza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Infectious Coryza Vaccine Players Market Share by Revenue
2.8.3 Global Infectious Coryza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infectious Coryza Vaccine Market Scenario by Region
3.1 Global Infectious Coryza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Infectious Coryza Vaccine Sales by Region: 2020-2031
3.2.1 Global Infectious Coryza Vaccine Sales by Region: 2020-2025
3.2.2 Global Infectious Coryza Vaccine Sales by Region: 2026-2031
3.3 Global Infectious Coryza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Infectious Coryza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Infectious Coryza Vaccine Revenue by Region: 2026-2031
3.4 North America Infectious Coryza Vaccine Market Facts & Figures by Country
3.4.1 North America Infectious Coryza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Infectious Coryza Vaccine Sales by Country (2020-2031)
3.4.3 North America Infectious Coryza Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infectious Coryza Vaccine Market Facts & Figures by Country
3.5.1 Europe Infectious Coryza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Infectious Coryza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Infectious Coryza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Coryza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Infectious Coryza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Infectious Coryza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Infectious Coryza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Infectious Coryza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Infectious Coryza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Infectious Coryza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Infectious Coryza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infectious Coryza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Coryza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Infectious Coryza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Infectious Coryza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infectious Coryza Vaccine Sales by Type (2020-2031)
4.1.1 Global Infectious Coryza Vaccine Sales by Type (2020-2025)
4.1.2 Global Infectious Coryza Vaccine Sales by Type (2026-2031)
4.1.3 Global Infectious Coryza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Infectious Coryza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Infectious Coryza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Infectious Coryza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Infectious Coryza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Infectious Coryza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Infectious Coryza Vaccine Sales by Application (2020-2031)
5.1.1 Global Infectious Coryza Vaccine Sales by Application (2020-2025)
5.1.2 Global Infectious Coryza Vaccine Sales by Application (2026-2031)
5.1.3 Global Infectious Coryza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Infectious Coryza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Infectious Coryza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Infectious Coryza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Infectious Coryza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Infectious Coryza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Infectious Coryza Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Infectious Coryza Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Infectious Coryza Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Company Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Santé Animale Infectious Coryza Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 Qilu Animal Health Products Co., Ltd.
6.5.1 Qilu Animal Health Products Co., Ltd. Company Information
6.5.2 Qilu Animal Health Products Co., Ltd. Description and Business Overview
6.5.3 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.5.5 Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
6.6 Tianjin Ruipu Biotechnology Co., Ltd.
6.6.1 Tianjin Ruipu Biotechnology Co., Ltd. Company Information
6.6.2 Tianjin Ruipu Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.6.5 Tianjin Ruipu Biotechnology Co., Ltd. Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.7.1 Harbin Pharmaceutical Group Company Information
6.7.2 Harbin Pharmaceutical Group Description and Business Overview
6.7.3 Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Harbin Pharmaceutical Group Infectious Coryza Vaccine Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Plyco Bioengineering Co., Ltd.
6.8.1 Plyco Bioengineering Co., Ltd. Company Information
6.8.2 Plyco Bioengineering Co., Ltd. Description and Business Overview
6.8.3 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
6.9 Qingdao Yibang Biological Engineering Co., Ltd.
6.9.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
6.9.2 Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
6.9.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.9.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
6.10 Shandong Lvdu Biological Technology Co., Ltd.
6.10.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
6.10.2 Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
6.10.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.10.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
6.11 Shandong Huahong Biological Engineering Co., Ltd.
6.11.1 Shandong Huahong Biological Engineering Co., Ltd. Company Information
6.11.2 Shandong Huahong Biological Engineering Co., Ltd. Description and Business Overview
6.11.3 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.11.5 Shandong Huahong Biological Engineering Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Coryza Vaccine Industry Chain Analysis
7.2 Infectious Coryza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Coryza Vaccine Production Mode & Process Analysis
7.4 Infectious Coryza Vaccine Sales and Marketing
7.4.1 Infectious Coryza Vaccine Sales Channels
7.4.2 Infectious Coryza Vaccine Distributors
7.5 Infectious Coryza Vaccine Customer Analysis
8 Infectious Coryza Vaccine Market Dynamics
8.1 Infectious Coryza Vaccine Industry Trends
8.2 Infectious Coryza Vaccine Market Drivers
8.3 Infectious Coryza Vaccine Market Challenges
8.4 Infectious Coryza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zoetis Inc
Merck
Boehringer Ingelheim
Ceva Santé Animale
Qilu Animal Health Products Co., Ltd.
Tianjin Ruipu Biotechnology Co., Ltd.
Harbin Pharmaceutical Group
Plyco Bioengineering Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Huahong Biological Engineering Co., Ltd.
List of Tables
 Table 1. Global Infectious Coryza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Infectious Coryza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Infectious Coryza Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Infectious Coryza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Infectious Coryza Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Infectious Coryza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Infectious Coryza Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Infectious Coryza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Infectious Coryza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Infectious Coryza Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Infectious Coryza Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Infectious Coryza Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Infectious Coryza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Coryza Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Infectious Coryza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Infectious Coryza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Infectious Coryza Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Infectious Coryza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Infectious Coryza Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Infectious Coryza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Infectious Coryza Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Infectious Coryza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Infectious Coryza Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Infectious Coryza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Infectious Coryza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Infectious Coryza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Infectious Coryza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Infectious Coryza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Infectious Coryza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Infectious Coryza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Infectious Coryza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Infectious Coryza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Infectious Coryza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Infectious Coryza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Infectious Coryza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Infectious Coryza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Infectious Coryza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Infectious Coryza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Coryza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Infectious Coryza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Infectious Coryza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Infectious Coryza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Infectious Coryza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Infectious Coryza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Infectious Coryza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Infectious Coryza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Infectious Coryza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Infectious Coryza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Infectious Coryza Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Infectious Coryza Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Infectious Coryza Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Infectious Coryza Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Infectious Coryza Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Infectious Coryza Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Infectious Coryza Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Infectious Coryza Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Infectious Coryza Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Infectious Coryza Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Infectious Coryza Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Infectious Coryza Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Infectious Coryza Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Infectious Coryza Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Infectious Coryza Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Infectious Coryza Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Infectious Coryza Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Infectious Coryza Vaccine Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Infectious Coryza Vaccine Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Santé Animale Company Information
 Table 86. Ceva Santé Animale Description and Business Overview
 Table 87. Ceva Santé Animale Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Santé Animale Infectious Coryza Vaccine Product
 Table 89. Ceva Santé Animale Recent Developments/Updates
 Table 90. Qilu Animal Health Products Co., Ltd. Company Information
 Table 91. Qilu Animal Health Products Co., Ltd. Description and Business Overview
 Table 92. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Product
 Table 94. Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
 Table 95. Tianjin Ruipu Biotechnology Co., Ltd. Company Information
 Table 96. Tianjin Ruipu Biotechnology Co., Ltd. Description and Business Overview
 Table 97. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Product
 Table 99. Tianjin Ruipu Biotechnology Co., Ltd. Recent Developments/Updates
 Table 100. Harbin Pharmaceutical Group Company Information
 Table 101. Harbin Pharmaceutical Group Description and Business Overview
 Table 102. Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Harbin Pharmaceutical Group Infectious Coryza Vaccine Product
 Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 105. Plyco Bioengineering Co., Ltd. Company Information
 Table 106. Plyco Bioengineering Co., Ltd. Description and Business Overview
 Table 107. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Product
 Table 109. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
 Table 110. Qingdao Yibang Biological Engineering Co., Ltd. Company Information
 Table 111. Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
 Table 112. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product
 Table 114. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
 Table 115. Shandong Lvdu Biological Technology Co., Ltd. Company Information
 Table 116. Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
 Table 117. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Product
 Table 119. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
 Table 120. Shandong Huahong Biological Engineering Co., Ltd. Company Information
 Table 121. Shandong Huahong Biological Engineering Co., Ltd. Description and Business Overview
 Table 122. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product
 Table 124. Shandong Huahong Biological Engineering Co., Ltd. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Infectious Coryza Vaccine Distributors List
 Table 128. Infectious Coryza Vaccine Customers List
 Table 129. Infectious Coryza Vaccine Market Trends
 Table 130. Infectious Coryza Vaccine Market Drivers
 Table 131. Infectious Coryza Vaccine Market Challenges
 Table 132. Infectious Coryza Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Infectious Coryza Vaccine
 Figure 2. Global Infectious Coryza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Coryza Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Monovalent Vaccine Product Picture
 Figure 5. Bivalent Vaccine Product Picture
 Figure 6. Trivalent Vaccine Product Picture
 Figure 7. Global Infectious Coryza Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Infectious Coryza Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Retail
 Figure 10. Online Sale
 Figure 11. Others
 Figure 12. Global Infectious Coryza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Infectious Coryza Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Infectious Coryza Vaccine Sales (2020-2031) & (K Units)
 Figure 15. Global Infectious Coryza Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Infectious Coryza Vaccine Report Years Considered
 Figure 17. Infectious Coryza Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Infectious Coryza Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Infectious Coryza Vaccine Players: Market Share by Revenue in Infectious Coryza Vaccine in 2024
 Figure 20. Infectious Coryza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Infectious Coryza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Infectious Coryza Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Infectious Coryza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Infectious Coryza Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Infectious Coryza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Infectious Coryza Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Infectious Coryza Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Infectious Coryza Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Infectious Coryza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Infectious Coryza Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Infectious Coryza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Infectious Coryza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Infectious Coryza Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Infectious Coryza Vaccine by Type (2020-2031)
 Figure 56. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Infectious Coryza Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Infectious Coryza Vaccine by Application (2020-2031)
 Figure 59. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Infectious Coryza Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Vaccine Against Infectious Coryza for Poultry Market Research Report 2024
Global Infectious Bursal Disease Vaccine Market Research Report 2024
Global Coccidiosis Vaccine for Chickens Market Research Report 2024
Global Marek s Disease Vaccine Market Research Report 2024
Global Chicken Newcastle Disease Vaccine Market Research Report 2024
Global Poultry Coccidiosis Vaccines Market Research Report 2025
Global Coccidia Virus Live Vaccine Market Research Report 2025
Global Diphtheria Vaccines Market Research Report 2024
Global Newcastle Disease Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Research Report 2025
Global Coccidiosis Vaccines Market Research Report 2024
Global Coccidiosis Vaccines in Chickens Market Research Report 2024
Global Newcastle Disease Vaccine Market Research Report 2025
Global Chicken Marek s Disease Live Vaccine Market Research Report 2024
Global Avian Pox Vaccine Market Research Report 2024
Global Mycoplasma Galliscepticum Vaccine Market Research Report 2024
Chicken Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Vaccines Market Research Report 2025
Poultry Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions